enclosed

:t iPOLYMED Poly Medicure Limited Regd. Office: 232 B, 3rd Floor, Okhla Industrial Estate, Phase-Ill, New Delhi -110 020 (INDIA) T: +91-11-33550700, 47317000 E: info@polymedicure.com W. polymedicure.com CIN: L 40300DL 1995PLC066923 Date: 10.08.2026 Scrip Code: -531768 Scrip Code:- POL YMED The Manager, The Manager BSE Limited, National Stock Exchange of India Limited Department of Corporclte rvicC:'s, x hange Plazc1, Plot No. C/l-Blork Phiroz Jeej ebhoy ow r , Bc1ndrc1 Kurla Complex, 13,111drc1( ), Dalal Str el, Mumbdi-400001. Mumbdi-400051. Reg: - Regulation 32 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"). Subject: - Statement of deviation(s) or variation(s), if any, of utilization of proceeds received from Qualified Institutions Placement (QIP). Dear Sir/Madam, We would like to inform Urnt the ompdny hc1d raised funds by wdy of allotment of 53,19,148 (Fifty Thre Lakh ineteen Thousand One Hundred Forty Eight) equity shares of face value of Rs. 5/- ed h, to qudlified institutional buyers ("QIBs"), at a price of Rs. 1880/- per Equity Shc1re (including premium of Rs. 1875/- per Equity Share), pursuant to the resolution passed by the Board of Dire tors dated 291" June, 2024, special resolution passed by the Shareholders through postal ballot on 5th August, 2024, the prelimindry placement do ument dated 19111 August, 2024, the placement document dc1ted 22nd August, 2024 dnd resolution of the QIP Committee of the Board of Directors ddted 22"'' August, 2024 (the "Issue"). We would further like to inform that the Audit ommittee, at it meeting held on August 07, 2026, hd reviewed the actual utilization of funds re eived for an amount aggregdting ~Rs 99,999.98 lakh, pursu,mt to the Issue. In U1is co,mection, we submit that there is no devidtion or vc1ric1tion from the objects of the Is ue, in the utilization of proceeds, as stated in U1e plc1cement document, during the quc1rter ended June 30, 2026. In terms of Regulations 32(1), 32(2) and 32(3) of U1e SEBI Listing Regulations, a statement of devidtion or variation, if any, in utilization of funds raised through Qualified Institutions Pia ement (QIP), for the quarter ended June 30, 2026, duly reviewed by U1e Audit Committee, in U1e pre cribed fom1at is dlso nclo ed herewith This is for your information dnd r ord. For Poly Medicure Limited Avinash Chandra Company Secretary M. No. A32270 Plants: Plot No. l04-105 & 115-116-117, Sector-59, HSIIDC Industrial Area, Ballabgarh, Faridabad -121004, Haryana (INDIA) Plot No. 33-34, Sector-68, IMT, Faridabad-121004, (Haryana) INDIA T: +91-129-4287000, 3355070 Statement of Deviation/Variation in utilization of funds raised Name of listed entity !Poly Medicure Limited Mode of Fund Raising Qualified Institutions Placement (QIP) Date of Raising Funds [ssue Open Date :19.08.2024 OCssue Closing Date :22.08.2024 •' Date of allotment of equity shares: 22.08.2024 !Amount Raised Rs 99,999.98 lakh (approx.) Report filed for Quarter ended une 30, 2026 Monitoring Agency ~pplkable Monitoring Agency Name, if applicable :RISIL Ratings Limited s there a Deviation/ Variation in use of funds raised NO f yes, whether the same is pursuant to change in terms Not Applicable of a contract or objects, which was approved by the shareholders f Yes, Date of shareholder Approval Not Applicable !Explanation for the Deviation/ Variation Not Applicable K:omments of the Audit Committee after review No comments t omments of the auditors, if any · No comments bbjects for which funds have been raised and where there has been a deviation, in the following table Original Obje~.t Modified briginal Modified !Funds Amount of Remarks if any Pbject, if IAJ.location allocation, if !Utilized till Deviation/ any (Amount any (Amount rune 30, Variation for ~n Lakhs) in Lakhs) ~026 he quarter (Amount in according to Lakhs) applicable Object (a) Funding capital expenditure N.A. 49,973.16 N.A. 8,117.62 N.A. No Deviation ~o be incurred by Company for !setting up of manufacnuing acilities. (b)Pursuing inorganic initiatives N.A. 25,026.84 N.A. 25,026.84 N.A. No Deviation (c) General corpo1:ate purposes N.A. 23,534.37 34.39 18,877.46 N.A. No Deviation rTotal 98,534.37 34.39 52,021.92 •(net of **(Modified issue allocation) expenses) *The actual issue proceeds come to ~Rs.99,999.98 lakh and as per placement document, the expenses related to the issue were estimated at Rs. 1500 Lakhs whereas after meeting all the QIP expenses, the same has come to Rs 1,465.61 lakh. Remaining surplus of Rs 34.39 lakh from issue expenses is added to the GCP, accordingly cost of GCP is revised from Rs 23,499.98 lakh as mentioned in the placement document to Rs 23,534.37 lakl1. Accordingly, the balance unutilized Rs 98,534.37 Lakhs were already transfened to the Monitoring Account on Rs 98,534.37 Lakhs. **During the quarter ended M,uch 31, 2025, the actual utilization of issue-related expenses was lower than the estimated amount disclose~ in the placement document, resulting in a surplus of Rs. 34.39 lakh. This surplus was adjusted against the GCP object, which increased the GCP amow1t to Rs. 23,53:1>:3 7·;-hl'kh and , .-,.._ \) t L U§ , consequently mcreased the net proceeds amount to Rs. 98,534.37 lakh. .' :s•0''-_ .. /,., ("", { ,-·a -' ,.:_ ~c,L\ .- I- ..... ...,_,,... )r Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in t.erms of a c~ i,t -i ferred to in the fund-raising document i.e., prospectus, letter of offer, etc. ' ,< •· .· ,' ., 'C)· , .,,,,:L~...:,.. .) 1- _· lj .~-- c.J; N J y rgiya \( -.__ ,,...J·/ . f p· ' I Off" •,.. ,', / Ch1e •1nanc1a .. icer '• • .•• - Date: 10.08.2026